MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 250 filers reported holding MEDIVATION INC in Q2 2014. The put-call ratio across all filers is 1.53 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $23,468,000 | +32.3% | 389,148 | +0.7% | 0.01% | +27.3% |
| Q1 2016 | $17,732,000 | -2.1% | 386,280 | +3.1% | 0.01% | 0.0% |
| Q4 2015 | $18,107,000 | +17.0% | 374,599 | +2.8% | 0.01% | +10.0% |
| Q3 2015 | $15,471,000 | -21.1% | 364,248 | +112.1% | 0.01% | -16.7% |
| Q2 2015 | $19,604,000 | +8.6% | 171,715 | +22.8% | 0.01% | +9.1% |
| Q1 2015 | $18,055,000 | +89.3% | 139,849 | +46.0% | 0.01% | +83.3% |
| Q4 2014 | $9,539,000 | +45.2% | 95,772 | +44.2% | 0.01% | +20.0% |
| Q3 2014 | $6,569,000 | -25.2% | 66,419 | -41.7% | 0.01% | -16.7% |
| Q2 2014 | $8,782,000 | +18.8% | 113,914 | -0.8% | 0.01% | 0.0% |
| Q1 2014 | $7,390,000 | +1.9% | 114,835 | +1.1% | 0.01% | 0.0% |
| Q4 2013 | $7,251,000 | +6.4% | 113,626 | -0.1% | 0.01% | 0.0% |
| Q3 2013 | $6,814,000 | +10.5% | 113,698 | -9.3% | 0.01% | 0.0% |
| Q2 2013 | $6,168,000 | – | 125,374 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |